New Publication Highlights Multidisciplinary Collaboration and Technological Innovations Shaping the Future of Hadron Therapy

​A recent publication in Technology in Cancer Research & Treatment highlights the pivotal role of multidisciplinary collaboration and technological innovation in advancing hadron therapy for cancer treatment. Authored by Manjit Dosanjh, Alberto Degiovanni, Maria Monica Necchi, and Elena Benedetto, the article emphasizes the precision and efficacy of hadron therapy, which utilizes accelerated beams of protons, carbon ions, and other charged particles to target tumors while sparing healthy tissue. ​ Despite over 350,000 patients treated with protons and 50,000 with carbon ions globally, hadron therapy remains relatively young, necessitating further research and the development of cost-effective, compact accelerator technologies to enhance global accessibility. The authors note that the first patient was treated with protons in September 1954, coinciding with CERN’s founding, both endeavors rooted in cutting-edge technologies and multidisciplinary collaboration. ​ The field continues to innovate, with advancements in accelerator-driven Boron Neutron Capture Therapy (BNCT), image-guided hadron beam delivery, clinical trials, immunotherapy, and the emerging interest in FLASH therapy—an experimental modality involving ultrahigh-dose rate delivery. These innovations aim to make hadron therapy more accessible to a larger patient population, underscoring the importance of collaborative efforts in overcoming current challenges and expanding treatment availability. ​ This publication serves as a testament to the ongoing commitment within the scientific and medical communities to harness multidisciplinary expertise and novel technologies in the fight against cancer, striving to improve patient outcomes and quality of life.​ https://www.researchgate.net/publication/388646356_Multidisciplinary_Collaboration_and_Novel_Technological_Advances_in_Hadron_Therapy